Jochem van Werkum

Showing 1-5 of 5 articles

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

Heestermans A, de Boer M, van Werkum J, Mosterd A, Gosselink A, Dambrink J, van Houwelingen K, Koopmans P, Hamm C, Zijlstra F, ten Berg J, van’t Hof A

August 30, 2011 | 10.4244/EIJV7I4A73

Triggering mechanisms of stent thrombosis

Zwart B, van Werkum J, Heestermans A, Kelder J, Zomer A, van’t Hof A, Verheugt F, ten Berg J

January 20, 2011

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial

Timmer J, ten Berg J, Heestermans A, Dill T, van Werkum J, Dambrink J, Suryapranata H, Ottervanger J, Hamm C, van’t Hof A

August 15, 2010

Platelet reactivity as a risk-factor for stent thrombosis: can this be one of the currently available appropriate methods to determine platelet reactivity?

van Werkum J, ten Berg J

August 20, 2008

Point-of-care platelet function testing in patients undergoing PCI: is it ready for use in clinical practice?

ten Berg J, van Werkum J

August 20, 2008

1

Latest news

The transcaval and transcarotid in TAVI, studies on the IMPella device, BRS and more

Example of CTCA reconstruction in a patient

February 7, 2020

New ahead of print: Validation of ARC-HBR criteria

February 18, 2020

New this week: FFR & myocardial mass, Chordae tendinea Rupture & more

February 18, 2020

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(The Trials book is supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

New Editor-in-Chief editorial. EuroIntervention: Moving forward

Davide Capodanno

February 7, 2020

EuroPCR, ESC 2020 - spotlight on “The Cutting Edge of Cardiology”

January 17, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke